Table 2 Changes in primary and secondary outcomes from baseline to week 10 and week 20: results from a complete case analysis
From: The effects of a digital health intervention on patient activation in chronic kidney disease
Number of participants | Mean change from baseline (95% CI) | Mean intervention effect (95% CI)a | P value | |||
|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | |||
Primary outcome | ||||||
PAM-13 | ||||||
Week 10 | 114 | 168 | 1.47 (95% CI: −0.81 to 3.74) | 2.97 (95% CI: 1.10 to 4.84) | 1.50 (95% CI: −1.44 to 4.45) | 0.316 |
Week 20 | 87 | 137 | 0.92 (95% CI: −1.61 to 3.45) | 4.12 (95% CI: 2.20 to 6.81) | 3.10 (95% CI: −0.19 to 6.39) | 0.065 |
Secondary outcomes | ||||||
CKD-SMKT – kidney health awareness | ||||||
Week 10 | 113 | 168 | −0.35 (95% CI: −0.47 to −0.22) | −0.45 (95% CI: -0.34 to -0.55) | −0.10 (95% CI: −0.26 to −0.06) | 0.225 |
Week 20 | 86 | 136 | −0.35 (95% CI: −0.50 to −0.21) | −0.52 (95% CI: −0.63 to −0.40) | −0.16 (95% CI: −0.35 to 0.02) | 0.083 |
CKD-SMKT – correct response | ||||||
Week 10 | 114 | 168 | 5.82 (95% CI: 1.8 to –9.77) | 9.65 (95% CI: 6.39 to 12.90) | 3.83 (95% CI: −1.29 to 8.95) | 0.142 |
Week 20 | 87 | 137 | 7.20 (95% CI: 2.06 to 12.34) | 7.43 (95% CI: 3.34 to 11.52) | 0.23 (95% CI: −6.34 to 6.80) | 0.945 |
CKD-SMKT – behaviours performed | ||||||
Week 10 | 98 | 142 | −0.66 (95% CI: −0.94 to −0.38) | −0.38 (95 CI: −0.62 to −0.15) | 0.28 (95% CI: −0.09 to 0.64) | 0.135 |
Week 20 | 73 | 111 | 0.28 (95% CI: 0.06 to 0.61) | 0.57 (95% CI: 0.30 to 0.84) | 0.30 (95%CI: -0.13 to 0.73) | 0.176 |
KSQ (frequency) | ||||||
Week 10 | 113 | 168 | 0.19 (95% CI: −0.86 to 1.23) | 0.28 (95% CI: −0.58 to 1.14) | 0.09 (95% CI: −1.26 to 1.45) | 0.893 |
Week 20 | 87 | 137 | 0.79 (95% CI: −0.47 to 2.06) | −0.52 (95% CI: −1.53 to 0.49) | −1.31 (95% CI: −2.93 to 0.31) | 0.111 |
UKDDQ | ||||||
Week 10 | 113 | 168 | −2.46 (95% CI: −3.58 to −1.34) | −1.18 (95% CI: −2.10 to −0.26) | 1.28 (95% CI: −0.17 to 2.73) | 0.083 |
Week 20 | 87 | 137 | 0.70 (95% CI: −0.53 to 1.93) | 2.51 (95% CI: 1.53 to 3.49) | 1.81 (95% CI: 0.24 to 3.38) | 0.024 |
MARS-5 | ||||||
Week 10 | 110 | 160 | 0.02 (95% CI: −0.28 to 0.33) | −0.15 (95% CI: −0.41 to 0.10) | −0.18 (95% CI: −0.57 to 0.21) | 0.371 |
Week 20 | 84 | 129 | −0.12 (95% CI: −0.45 to 0.21) | 0.06 (95% CI: −0.20 to 0.33) | 0.18 (95% CI: −0.24 to 0.61) | 0.391 |
SARC-F | ||||||
Week 10 | 114 | 168 | 0.09 (95% CI: −0.12 to 0.29) | 0.07 (95% CI: −0.09 to 0.24) | −0.01 (95% CI: −0.27 to 0.25) | 0.933 |
Week 20 | 87 | 137 | 0.19 (95% CI: −0.01 to 0.40) | −0.10 (95% CI: −0.27 to 0.07) | −0.29 (95% CI: −0.56 to −0.18) | 0.037 |
STS-60 | ||||||
Week 10 | 98 | 149 | 0.40 (95% CI: −0.75 to 1.54) | 1.27 (95% CI: 0.34 to 2.20) | 0.87 (95% CI: −0.60 to 2.35) | 0.243 |
Week 20 | 77 | 117 | 0.68 (95% CI: −0.99 to 2.35) | 2.76 (95% CI: 1.40 to 4.11) | 2.07 (95% CI: −0.08 to 4.23) | 0.059 |
